Researchers found a proven and effective osteoporosis medication, which is currently only available as an injection, can now be administered orally via a novel robotic pill.
According to a new study presented at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill., breast cancer treatments known as aromatase inhibitors may reduce the effect of weight reduction therapies.
Researchers identified the beneficial changes that occur naturally in the immune system during pregnancy.
The study was published in 'Journal of Neuroinflammation'
Debilitating cognitive deficiencies frequently accompany mood disorders and other mental illnesses. There are presently few therapies available, however research in both animals and people has suggested that medications that stimulate serotonin receptors, such the laxative prucalopride, may
According to the findings of a recent study that followed the problem over a 16-year period, elevated levels of Lipoprotein(a), a subtype of "bad cholesterol," in bloodstreams are a risk factor for recurrent coronary heart disease (CHD) in adults 60 and older.
The results, published today i
Minneapolis [US], June 10: A new study published in The LancetInfectious Diseases supported by the Parsemus Foundation found a 41 per cent reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42 per cent reduction in emergency roo
A new targeted therapy medicine can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening, according to an international trial co-led by UCLA. The discovery provides a potential new therapeutic option for those suffering from the slow-growi
Blood pressure is frequently measured in hospitalised patients. Severe hypertension can result in a heart attack, stroke, or damage to blood vessels and organs such the heart, brain, kidneys, and eyes. The majority of hospitalised patients, on the other hand, have transiently elevated blood
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
The launch makes the UAE one of the first countries in the Middle East to receive access to the medication that marks a significant advancement in the treatment of cancer.
According to findings of recent clinical research, the first medication therapy to reduce the onset of nearsightedness in children may be on the horizon.
Dementia is described as a loss of cognitive functioning, which included thinking, remembering, and reasoning, and it is quite common in Japan. At the moment, treatment satisfaction for dementia is among the lowest, and no medication therapy to cure the condition is available. With the world